Enveda Biosciences

Developer of a drug analysis platform designed to capitalize on the chemical diversity and evolutionary significance to create better medicines faster. The company's platform combines machine learning, metabolomics, and robotics to analyze a natural sample for both chemical structure and biological activity and function, eliminating the need for isolating individual compounds or conducting extensive experimentation, enabling clients in the healthcare industry to form new antibiotics to hypotensives and to identify and characterize a wide range of molecules produced by living organisms.

Lux Capital

🏥 Healthcare